Phase II study of ionidamine in patients with metastatic breast cancer
Robins, H. Ian ; Neuberg, Donna S. ; Benson, Al B. ; Pandya, Kishan J. ; Tormey, Douglass C.
Springer
Published 1990
Springer
Published 1990
| ISSN: |
1573-0646
|
|---|---|
| Keywords: |
lonidamine ; breast cancer
|
| Source: |
Springer Online Journal Archives 1860-2000
|
| Topics: |
Chemistry and Pharmacology
Medicine
|
| Notes: |
Summary The Eastern Cooperative Oncology Group conducted a phase II study of lonidamine in patients with metastatic breast cancer. The drug was given orally to a maximum daily dose of 340 mg/m2. Forty-two patients were entered on study. One partial response was observed; there were no life-threatening toxicities. The results of this study are compared to two similar phase II trials.
|
| Type of Medium: |
Electronic Resource
|
| URL: |